Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

European Medicines Agency

Dutch government sets up relocation help desk for EMA staff

EMA building Canary Wharf London

Source: Shutterstock.com

Dutch government has set up a helpdesk for staff in the EMA’s London headquarters (above)

A help desk has been established at the London headquarters of the European Medicines Agency (EMA) to support staff relocating to its new headquarters in Amsterdam.

The desk, which opened on 8 December, has been set up by the Dutch authorities behind the successful relocation bid — which includes the government and Amsterdam city council — in an attempt to make the transition from London to the Netherlands as seamless as possible.

Details of the desk were revealed by the government of the Netherlands in a statement.

It said: “The help desk is part of the Dutch pledge to make the relocation of EMA and its staff as smooth as possible. 

“In London, the help desk will organise information sessions on living in the Netherlands, housing and education. The first information sessions will take place […] before the end of the year.”

The desk can tackle staff’s general questions about relocating on issues such as medical care, partner relocation, education and residence permits.

From February the service will be expanded to provide one-on-one sessions with EMA staff, with the aim of creating tailored support, the government said.

The EMA said on 12 December that it was still working on producing a monitoring chart, originally promised to be available early December, which it intends to publicise on its website to track relocation progress. It was unable to say when the chart would be ready. 

The European Council announced in November that Amsterdam was its choice to host the EMA after the UK leaves the European Union (EU) in March 2019.

The EMA will move from Canary Wharf to new purpose-built offices in the heart of Amsterdam’s business quarter.

The city was the first choice of the EMA’s 900 staff from the 19 shortlisted destinations, according to the results of an employee survey.

Plans for the move start to take shape at the same time as the Netherlands’ government is pushing ahead with its promise to invest an extra €2m to increase the capacity of its medicines safety watchdog the Dutch Medicines Board, ahead of Brexit. 

It has also pledged another €8m to develop expertise and IT co-operation between EU national medicines agencies. The money will help fund an in-depth training programme for boosting the assessment capacity within those EU states and help fill the gap created by the UK leaving the EMA.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2017.20204108

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.

Visit rpharms.com

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • EMA building Canary Wharf London

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.